Consider sputum sample and screening for viral, opportunistic or specific bacterial infections (mycoplasma, legionella) depending on the clinical contact
Management escalation pathway
Withhold ICPi
Monitor symptoms daily: hospitalize patient
Start antibiotic if suspicion of infection (fever, CRP, neutrophil counts, purulent sputa)
If no evidence of infection or no improvement with antibiotics after 48h add (methyl)prednisolone 1 mg/kg/day orally
If no improvement after 48h of oral prednisolone, manage as per Grade 3
Consider Pneumocystis prophylaxis depending on the clinical context (especially in immunosuppressed patients)
Assessment and Investigations
High resolution CT
Regular blood analysis including CRP
Analyse sputum sample (incl screening for viral, opportunistic or specific bacterial infections (mycoplasma, legionella))
Discuss bronchoscopy and BAL with pneumologist
Perform lung function tests, including TCLO
Management escalation pathway
Discontinue ICPi
Hospitalize patient, consider ICU care
Start (methyl)prednisolone i.v. 2 mg/kg/day + cover with empiric antibiotics
consider treatment with cotrimoxazole for Pneumocystis
Assessment and investigations
Perform blood test
Analyze sputum for bacteria, viral and other opportunistic infections
High resolution CT
Bronchoscopy and BAL as well as lung function tests to be discussed with pneumologist
If no improvement or worsening after 48h
Discuss addition of Infliximab 5 mg/kg or other secondary immunosuppressant with pneumologist or in multidisciplinary board
Continue with i.v. steroids
Exclude other diagnosis including diaphragm paralysis due to concurrent immune related (cardio)myositis
Past or ongoing infectious diseases: HIV, Influenza, Mycobacterium Tuberculosis exposure
Smoking, travel and allergens history (including exposure to home occupational aeroallergens)
Differential Diagnosis
other causes of pneumonia (including atypical pneumonia, Pneumocystis, Tuberculosis, …)
Carcinomatous lymphangitis
Pulmonary oedema
Pulmonary emboli
Sarcoidosis
Steroid weaning upon symptom control
Grade 2: wean oral steroids over at least 6 weeks, titrate to symptoms
Grade 3/4: wean steroids over at least 8 weeks
Caution during steroid treatment:
Calcium & vitamin D supplementation as per local guidelines
Pneumocystis prophylaxis to be considered: Cotrimoxazol 480mg bi-daily 3 times a week
Restart immunotherapy
Should be discussed multidisciplinary among oncologist and pneumologist patient should be included in risk assessment (only 7 out 10 cases of pneumonitis had a relaps of pneumonitis upon ICPI restart https://www.ncbi.nlm.nih.gov/pubmed/28798088)
Only indicated once steroids are completely weaned and CT lung is completely cleared